THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Koc, Basak [1 ,2 ]
Zulfikar, Bulent [1 ,2 ]
机构：
[1] IU Cerrahpasa Med Fac, Istanbul, Turkey
[2] Inst Oncol, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
689
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
    Michael S. Mathisen
    Susan O’Brien
    Deborah Thomas
    Jorge Cortes
    Hagop Kantarjian
    Farhad Ravandi
    Current Hematologic Malignancy Reports, 2011, 6
  • [2] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Mathisen, Michael S.
    O'Brien, Susan
    Thomas, Deborah
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 187 - 194
  • [3] Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (02): : 198 - 203
  • [4] Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors
    Abou Dalle, Iman
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Konopleva, Marina
    Jain, Nitin
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Qiao, Wei
    Cortes, Jorge E.
    O'Brien, Susan
    Kebriaei, Partow
    Kadia, Tapan
    Jabbour, Elias
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1388 - 1395
  • [5] Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
    Yu, Guopan
    Chen, Fang
    Yin, Changxin
    Liu, Qifa
    Sun, Jing
    Xuan, Li
    Fan, Zhiping
    Wang, Qiang
    Liu, Xiaoli
    Jiang, Qianli
    Xu, Dan
    ONCOTARGET, 2017, 8 (63): : 107022 - 107032
  • [6] Intensive chemotherapy with tyrosine kinase inhibitors in philadelphia-positive acute lymphoblastic leukemia
    Benavente, Rafael
    Cid, Fernando
    Puga, Barbara
    Molina, Javiera
    Bass, Francisca
    Andrade, Alejandro
    Monardes, Virginia
    Encina, Andrea
    Elena Cabrera, Maria
    REVISTA MEDICA DE CHILE, 2021, 149 (09) : 1249 - 1257
  • [7] Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    Piccaluga, Pier Paolo
    Paolini, Stefania
    Martinelli, Giovanni
    CANCER, 2007, 110 (06) : 1178 - 1186
  • [8] Predictors of Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at First Relapse in the Era of Tyrosine Kinase Inhibitors
    Aboudalle, Iman
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Konopleva, Marina Y.
    Jain, Nitin
    Garcia-Manero, Guillermo
    Garris, Rebecca E.
    Qiao, Wei
    Cortes, Jorge E.
    O'Brien, Susan M.
    Kebriaei, Partow
    Kadia, Tapan M.
    Jabbour, Elias J.
    Ravandi, Farhad
    BLOOD, 2018, 132
  • [9] Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia
    Klyuchnikov, Evgeny
    Schafhausen, Philippe
    Kroeger, Nicolaus
    Brummendorf, Tim H.
    Osanmaz, Okay
    Asenova, Svetlana
    Zabelina, Tatjana
    Ocheni, Sunday
    Ayuk, Francis
    Zander, Axel R.
    Bacher, Ulrike
    ACTA HAEMATOLOGICA, 2009, 122 (01) : 6 - 10
  • [10] Impact of Tyrosine Kinase Inhibitors on Minimal Residual Disease and Outcome in Childhood Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Jeha, Sima
    Coustan-Smith, Elaine
    Pei, Deqing
    Sandlund, John T.
    Rubnitz, Jeffrey E.
    Howard, Scott C.
    Inaba, Hiroto
    Bhojwani, Deepa
    Metzger, Monika L.
    Cheng, Cheng
    Choi, John K.
    Jacobsen, Jeffrey
    Shurtleff, Sheila A.
    Raimondi, Susana
    Ribeiro, Raul C.
    Pui, Ching-Hon
    Campana, Dario
    CANCER, 2014, 120 (10) : 1514 - 1519
12345